0.89 0.12 (15.58%)

87.81% Fall from 52W High

4.7M XNAS Volume

High volume+gain today

XNAS 28 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Conduit Pharmaceuticals Inc

The latest disclosure was made by Chiavacci Chele Farley in Conduit Pharmaceuticals Inc where a trade of 420,000 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 18, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Chiavacci Chele Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 420,000 420,000 - - Stock Option (Right to Buy)
Freda Lewis-Hall C. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 420,000 420,000 - - Stock Option (Right to Buy)
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 420,000 420,000 - - Stock Option (Right to Buy)
Fry Simon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 420,000 420,000 - - Stock Option (Right to Buy)
James Bligh Director, Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 1,890,000 1,890,000 - - Stock Option (Right to Buy)
David Tapolczay Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 840,000 840,000 - - Stock Option (Right to Buy)
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.09 per share. 18 Nov 2024 299,238 351,510 - 0.1 27,500 Common Stock
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 75,000 75,000 - - Common Stock
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.09 per share. 18 Nov 2024 266,594 341,594 - 0.1 24,500 Common Stock
Freda C. Lewis-Hall Director Grant, award, or other acquisition of securities at price $ 0.09 per share. 18 Nov 2024 437,976 437,976 - 0.1 40,250 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.25 per share. 14 Jun 2024 1,389,820 12,941,319 - 0.2 343,425 Common Stock
Andrew James Regan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 14 Jun 2024 1,100,000 15,478,695 - - Common Stock
Andrew James Regan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 14 Jun 2024 1,100,000 30,048,454 - - Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.26 per share. 14 Jun 2024 1,514,100 177,627 - 0.3 391,092 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.32 per share. 14 Jun 2024 10,244,392 1,691,727 - 0.3 3,246,448 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.25 per share. 14 Jun 2024 1,005,200 11,936,119 - 0.2 248,385 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.29 per share. 14 Jun 2024 300,000 14,331,139 - 0.3 87,000 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.30 per share. 14 Jun 2024 582,952 14,631,139 - 0.3 173,253 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.33 per share. 14 Jun 2024 150,000 15,214,091 - 0.3 50,070 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.44 per share. 14 Jun 2024 77,681 15,364,091 - 0.4 33,853 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.51 per share. 14 Jun 2024 35,923 15,441,772 - 0.5 18,321 Common Stock
Andrew James Regan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.64 per share. 14 Jun 2024 1,000 15,477,695 - 0.6 640 Common Stock
James Bligh Director, Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 37,272 37,272 - - Common Stock
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 37,272 52,272 - - Common Stock
Adam Sragovicz Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 May 2024 74,545 0 - 0 Restricted Stock Units
Jennifer I. McNealey Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 May 2024 65,000 0 - - Stock Option (Right to Buy)
Freda C. Lewis-Hall Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2024 400,664 400,664 - - Warrant (Right to buy)
David Tapolczay Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Apr 2024 200,332 200,332 - - Warrant (Right to buy)
David Tapolczay Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2024 400,664 400,664 - - Warrant (Right to buy)
Chele Chiavacci Farley Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Apr 2024 200,332 203,332 - - Warrant (Right to buy)
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2024 3,000 3,000 - - Warrant (Right to buy)
Freda C. Lewis-Hall Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2024 103,397 103,397 - - Warrant (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures